Nephrology and Chronic Kidney Disease
Modus Therapeutics AB is focused on clinical research in chronic kidney disease, with attention to kidney function, glomerular filtration rate, and related clinical measures of renal impairment.
- Glomerular filtration rate
- Kidney function
- Renal impairment
The sponsor’s current research activity is centered on kidney disease management and the clinical characterization of patients with reduced renal function.
Haematology and Anaemia
Its trial activity includes evaluation of haematological parameters linked to anaemia in the setting of kidney disease, reflecting interest in blood-related complications associated with impaired renal function.
- Anaemia
- Haematological parameters
- Blood-related complications
These areas indicate a therapeutic focus on clinical changes affecting red blood cell status and related laboratory findings in patients with CKD.
Biochemistry and Renal Biomarkers
The sponsor also studies biochemical parameters associated with kidney disease, including markers relevant to renal status and systemic effects of impaired kidney function.
- Biochemical parameters
- Renal biomarkers
- Systemic effects
This research domain supports clinical assessment of disease-related laboratory changes in people with chronic kidney disease.
Pharmacokinetics and Individualised Dosing
Modus Therapeutics AB is engaged in research linking pharmacokinetic parameters with kidney function to inform individualised dosing approaches in patients with reduced renal clearance.
- Pharmacokinetic parameters
- Individualised dosing
- Renal clearance
This area reflects therapeutic interest in adapting treatment to the level of kidney function in CKD.
